Owner & Director
David is a European patent attorney, chartered UK patent attorney and a patent attorney litigator with nearly two decades' experience in the profession. David handles work in the life science, chemical and mechanical engineering fields including medical devices, therapeutics (both traditional pharmaceuticals and biomolecules), biopolymers, nutraceuticals, encapsulation, diagnostics and stem cell technologies.
Prior to joining the patent profession, David worked for a multi-national organisation gaining valuable insight into the challenges faced by industry and understands at first hand the need to balance any IP strategy with the commercial aims and budget of a business. David is experienced in drafting and prosecuting patent applications worldwide, providing validity and freedom-to-operate opinions and advising on a range of intellectual property matters. He is also experienced in representing clients in opposition and appeal proceedings before the European Patent Office (EPO). David has acted for a wide spectrum of clients, ranging from large multinational companies to SMEs, start-ups, entrepreneurs, universities and associated spin-out companies.
David is co-chair of the international sub-committee of the American Intellectual Property Law Association’s (AIPLA) biotechnology committee.
David is a frequent speaker at events and has presented at international intellectual property conferences. David is also a speaker at Fleming Europe’s Pharmaceutical & Biotechnology Litigation training course.
Legal 500 recognises David as providing "very thorough, intelligent advice”.
David's Technical Expertise